-
-
-
-
-
-
-
CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook
-
-
-
-
-
-
-
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Vertex Pharma (VRTX) Announces FDA Acceptance of BLA for exagamglogene autotemcel for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
-
-
-
-
-
-
-
Pre-Open Movers 01/03: (SCG) (HGSH) (TRVN) Higher; (CYH) (MGI) (D) Lower (more...)
15,740 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

